123I-MIBG cardiac uptake and smell identification in parkinsonian patients with LRRK2 mutations

Journal of Neurology

Volumn 258, Issue 6, 2011, Pages 1126-1132

  Valldeoriola, Francesc ^a   Gaig, Carles ^a   Muxí, Africa ^a   Navales, Ignacio ^a   Paredes, Pilar ^a   Lomeña, Francisco ^a   De La Cerda, Andres ^a   Buongiorno, Mariateresa ^a   Ezquerra, Mario ^a   Santacruz, Pilar ^a   Martí, Maria Jose ^a   Tolosa, Eduardo ^a  

^a UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Genetics; Lewy bodies; Parkinson's disease; Smell; SPECT

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; LEVODOPA; POTASSIUM IODIDE; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; GLYCINE; LRRK2 PROTEIN, HUMAN; PROTEIN SERINE THREONINE KINASE; RADIOPHARMACEUTICAL AGENT; SERINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEGENERATIVE DISEASE; DIAGNOSTIC VALUE; DISEASE DURATION; DISEASE SEVERITY; DRUG UPTAKE; FEMALE; GAMMA SCINTIGRAPHY; GENE MUTATION; HEART SCINTISCANNING; HUMAN; LEWY BODY; MALE; NEUROLOGIC DISEASE; ODOR; OLFACTORY NERVOUS SYSTEM; PARKINSON DISEASE; PARKINSONISM; PRIORITY JOURNAL; SCINTILLATION CAMERA; SCORING SYSTEM; SMELLING; UNIFIED PARKINSON DISEASE RATING SCALE; GENETICS; HEART; HOSPITALIZATION; MIDDLE AGED; NONPARAMETRIC TEST; PHYSIOLOGY; SCINTISCANNING; SINGLE NUCLEOTIDE POLYMORPHISM;

3-IODOBENZYLGUANIDINE; ADULT; AGED; AGED, 80 AND OVER; FEMALE; GLYCINE; HEART; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; PARKINSONIAN DISORDERS; POLYMORPHISM, SINGLE NUCLEOTIDE; PROTEIN-SERINE-THREONINE KINASES; RADIOPHARMACEUTICALS; SERINE; SEVERITY OF ILLNESS INDEX; SMELL; STATISTICS, NONPARAMETRIC;

EID: 79959814706     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-010-5896-6     Document Type: Article

References (40)

1. A Zimprich S Biskup P Leitner P Lichtner M Farrer S Lincoln, et al. 2004 Mutations in LRRK2 cause autosomal-dominant parkinsonism with pleomorphic pathology Neuron 44 601 607 10.1016/j.neuron.2004.11.005 1:CAS:528: DC%2BD2cXhtVKhurjL 15541309 (Pubitemid 39531225)
2. WP Gilks PM Abou-Sleiman S Gandhi S Jain A Singleton AJ Lees, et al. 2005 A common LRRK2 mutation in idiopathic Parkinson's disease Lancet 365 415 416 1:CAS:528:DC%2BD2MXoslWitQ%3D%3D 15680457 (Pubitemid 40179229)
3. C Gaig M Ezquerra MJ Martí E Muñoz F Valldeoriola E Tolosa 2006 LRRK2 mutations in Spanish patients with Parkinson's disease: frequency, clinical features and incomplete penetrance Arch Neurol 63 377 382 10.1001/archneur.63.3.377 16533964
4. M Funayama K Hasegawa E Ohta N Kawashima M Komiyama H Kowa, et al. 2005 An LRRK2 mutation as a cause for the parkinsonism in the original PARK8 family Ann Neurol 57 918 921 10.1002/ana.20484 1:CAS:528:DC%2BD2MXlslKks7k%3D 15880653 (Pubitemid 40798631)
5. BI Giasson JP Covy NM Bonini HI Hurtig MJ Farrer JQ Trojanowski, et al. 2006 Biochemical and pathological characterization of LRRK2 Ann Neurol 59 315 322 10.1002/ana.20791 1:CAS:528:DC%2BD28XhvVSks70%3D 16437584 (Pubitemid 43202485)
6. A Rajput DW Dickson CA Robinson OA Ross JC Dächsel SJ Lincoln, et al. 2006 LRRK2 G2019S, and tau neuropathology Neurology 67 1506 1508 10.1212/01.wnl.0000240220.33950.0c 1:CAS:528:DC%2BD28XhtVKrt7jN 17060589 (Pubitemid 44632090)
7. C Gaig MJ Marti M Ezquerra MJ Rey A Cardozo E Tolosa 2007 G2019S LRRK2 mutation causing Parkinson's disease without Lewy bodies J Neurol Neurosurg Psychiatry 78 626 628 10.1136/jnnp.2006.107904 17210620 (Pubitemid 46853900)
8. C Gaig M Ezquerra MJ Martí F Valldeoriola E Muñoz A Lladó, et al. 2008 Screening for the LRRK2 G2019S and codon-1,441 mutations in a pathological series of parkinsonian syndromes and frontotemporal lobar degeneration J Neurol Sci 270 94 98 10.1016/j.jns.2008.02.010 1:CAS:528:DC%2BD1cXmvVOgtro%3D 18353371 (Pubitemid 351766729)
9. JF Martí-Massó J Ruiz-Martínez MJ Bolaño I Ruiz A Gorostidi F Moreno, et al. 2009 Neuropathology of Parkinson's disease with the R1441G mutation in LRRK2 Mov Disord 24 1998 2001 10.1002/mds.22677 19735093
10. S Orimo T Amino Y Itoh A Takahashi T Kojo T Uchihara, et al. 2005 Cardiac sympathetic denervation precedes neuronal loss in the sympathetic ganglia in Lewy body disease Acta Neuropathol 109 583 588 10.1007/s00401-005-0995-7 15933869 (Pubitemid 40974147)
11. S Orimo A Takahashi T Uchihara F Mori A Kakita K Wakabayashi, et al. 2007 Degeneration of cardiac sympathetic nerve begins in the early disease process of Parkinson's disease Brain Pathol 17 24 30 10.1111/j.1750-3639.2006.00032.x 1:CAS:528:DC%2BD2sXkvFSiu7g%3D 17493034
12. S Orimo T Oka H Miura K Tsuchiya F Mori K Wakabayashi, et al. 2002 Sympathetic cardiac denervation in Parkinson's disease and pure autonomic failure but not in multiple system atrophy J Neurol Neurosurg Psychiatry 73 776 777 10.1136/jnnp.73.6.776 1:STN:280:DC%2BD38jhs1GqsQ%3D%3D 12438492 (Pubitemid 35448873)
13. S Orimo E Ozawa S Nakade H Hattori K Tsuchiya A Takahashi 2003 [123]MIBG myocardial scintigraphy differentiates corticobasal degeneration from Parkinson's disease Intern Med 42 127 128 10.2169/internalmedicine.42.127 12583635 (Pubitemid 36267681)
14. C Hawkes 2004 Olfactory testing in parkinsonism Lancet Neurol 3 393 394 10.1016/S1474-4422(04)00801-4 15207792 (Pubitemid 38789132)
15. L Silveira-Moriyama JL Holton A Kingsbury H Ayling A Petrie W Sterlacci, et al. 2009 Regional differences in the severity of Lewy body pathology across the olfactory cortex Neurosci Lett 453 77 80 10.1016/j.neulet.2009.02.006 1:CAS:528:DC%2BD1MXivVelu7o%3D 19356597
16. RL Doty LI Golbe DA McKeown MB Stern CM Lehrach D Crawford 1993 Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease Neurology 43 962 965 1:STN:280:DyaK3s3mtFKiuw%3D%3D 8492953 (Pubitemid 23150569)
17. RH McShane Z Nagy MM Esiri E King C Joachim N Sullivan, et al. 2001 Anosmia in dementia is associated with Lewy bodies rather than Alzheimer's pathology J Neurol Neurosurg Psychiatry 70 739 743 10.1136/jnnp.70.6.739 1:STN:280:DC%2BD3MzhtF2qtA%3D%3D 11385006 (Pubitemid 32554203)
18. AJ Hughes SE Daniel L Kilford AJ Lees 1992 Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases J Neurol Neurosurg Psychiatry 55 181 184 10.1136/jnnp.55.3.181 1:STN:280:DyaK383is1Omsg%3D%3D 1564476
19. KK Solanki J Bomanji J Moyes SJ Mather PJ Trainer KE Britton 1992 A pharmacological guide to medicines which interfere with the biodistribution of radiolabelled meta-iodobenzylguanidine (MIBG) Nucl Med Commun 13 513 521 10.1097/00006231-199207000-00006 1:CAS:528:DyaK38XmtVOqtb0%3D 1495678
20. D Lafreniere N Mann 2009 Anosmia: loss of smell in the elderly Otolaryngol Clin North Am 41 123 131 10.1016/j.otc.2008.09.001
21. A Quattrone A Bagnato G Annesi F Novellino L Morgante G Savettieri, et al. 2008 Myocardial 123metaiodobenzylguanidine uptake in genetic Parkinson's disease Mov Disord 23 21 27 10.1002/mds.21701 17975812 (Pubitemid 351281213)
22. H Tomiyama Y Li M Funayama K Hasegawa H Yoshino S Kubo, et al. 2006 Clinicogenetic study of mutations in LRRK2 exon 41 in Parkinson's disease patients from 18 countries Mov Disord 21 1102 1108 10.1002/mds.20886 16622854 (Pubitemid 44336593)
23. L Silveira-Moriyama LC Guedes A Kingsbury H Ayling K Shaw ER Barbosa, et al. 2008 Hyposmia in G2019S LRRK2-related parkinsonism: clinical and pathologic data Neurology 71 1021 1026 10.1212/01.wnl.0000326575.20829.45 1:CAS:528:DC%2BD1cXhtFartL%2FL 18809839
24. S Orimo T Amino M Yokochi T Kojo T Uchihara A Takahashi, et al. 2005 Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2 Mov Disord 20 1350 1353 10.1002/mds.20594 16001409 (Pubitemid 41645912)
25. 123I-metaiodbenzylguanidine uptake in autosomal recessive juvenile parkinsonism: first case report Mov Disord 20 634 636 10.1002/mds.20384 15704207 (Pubitemid 40862267)
26. NL Khan R Katzenschlager H Watt KP Batia NW Wood N Quinn, et al. 2004 Olfaction differentiates parkin disease from early-onset parkinsonism and Parkinson disease Neurology 62 1224 1226 1:STN:280:DC%2BD2c7otlGlug%3D%3D 15079034 (Pubitemid 38456528)
27. H Mori T Kondo M Yokochi H Matsumine Y Nakagawa Hattori T Miyake, et al. 1998 Pathological and biochemical studies of juvenile parkinsonism linked to chromosome 6q Neurology 51 890 892 1:STN:280:DyaK1cvhvVynug%3D%3D 9748052 (Pubitemid 28449284)
28. S Hayashi K Wakabayashi A Ishikawa H Nagai M Saito M Muruyama, et al. 2000 An autopsy case of autosomal-recessive juvenile parkinsonism with a homozygous exon 4 deletion in the parkin gene Mov Disord 15 884 888 10.1002/1531-8257(200009)15:5<884::AID-MDS1019>3.0.CO;2-8 1:STN:280:DC%2BD3cvlt1yitg%3D%3D 11009195
29. AS Chen-Plotkin W Yuan C Anderson EM Wood HI Hurtig CM Clark, et al. 2008 Corticobasal syndrome and primary progressive aphasia as manifestations of LRRK2 gene mutations Neurology 70 521 527 10.1212/01.WNL.0000280574.17166.26 1:CAS:528:DC%2BD1cXhsVyqu7Y%3D 17914064 (Pubitemid 351653376)
30. 123I metaiodobenzylguanidine myocardial scintigraphy in Parkinson's disease J Neurol Neurosurg Psychiatry 67 189 194 10.1136/jnnp.67.2.189 1:STN:280: DyaK1MzjslOmtg%3D%3D 10406987 (Pubitemid 29326950)
31. F Courbon C Brefel-Courbon C Thalamas MJ Alibelli I Berry JL Montastruc, et al. 2003 Cardiac MIBG scintigraphy is a sensitive tool for detecting cardiac sympathetic denervation in Parkinson's disease Mov Disord 18 890 897 10.1002/mds.10461 12889078 (Pubitemid 37021163)
32. CA Haensch H Lerch J Jörg S Isenmann 2009 Cardiac denervation occurs independent of orthostatic hypotension and impaired heart rate variability in Parkinson's disease Parkinsonism Relat Disord 15 134 137 10.1016/j.parkreldis. 2008.04.031 18515170
33. ED Louis K Marder MH Tabert DP Devanand 2008 Mild Parkinsonian signs are associated with lower olfactory test scores in the community-dwelling elderly Mov Disord 23 524 530 10.1002/mds.21777 18098296
34. A Haehner T Hummel C Hummel U Sommer S Junghanns H Reichmann 2007 Olfactory loss may be a first sign of idiopathic Parkinson's disease Mov Disord 22 839 842 10.1002/mds.21413 17357143 (Pubitemid 46800106)
35. M Iijima M Osawa M Momose T Kobayakawa S Saito M Iwata, et al. 2010 Cardiac sympathetic degeneration correlates with olfactory function in Parkinson's disease Mov Disord 25 1143 1149 10.1002/mds.23001 20131383
36. 123I-MIBG and odor identification in patients with Parkinson's disease and multiple system atrophy Mov Disord 21 1975 1977 10.1002/mds.21083 16960860 (Pubitemid 44848949)
37. DS Goldstein L Sewell C Holmes 2010 Association of anosmia with autonomic failure in Parkinson disease Neurology 74 245 251 10.1212/WNL.0b013e3181ca014c 20083801
38. H Nagayama M Hamamoto M Ueda Y Nishiyama M Hamamoto Y Katayama 2005 Reliability of MIBG myocardial scintigraphy in the diagnosis of Parkinson's disease J Neurol Neurosurg Psychiatry 76 249 251 10.1136/jnnp.2004.037028 1:STN:280:DC%2BD2M%2FislSrtw%3D%3D 15654042 (Pubitemid 40143717)
39. 123I-MIBG uptake in Parkinson's disease J Neurol Neurosurg Psychiatry 74 423 426 10.1136/jnnp.74.4.423 1:STN:280:DC%2BD3s7isF2qsA%3D%3D 12640054 (Pubitemid 36379361)
40. 123I-MIBG scintigraphy can assess the disease severity and phenotype of PD J Neurol Sci 220 105 111 10.1016/j.jns.2004.02.018 15140615 (Pubitemid 38622107)